Paul Diaz is President & CEO of Myriad Genetics. Thirty years ago, Myriad Genetics played a pivotal role in one of the most important breakthroughs in the history of healthcare: discovering the precise location and sequence of the BRCA1 and BRCA2 genes, which increase the risk of breast cancer. This led to the emergence of genetic testing as a tool that has saved millions of lives. Now, with Paul at the helm, Myriad Genetics aims to play as pivotal a role in the next 30 years of genetics and precision medicine as they did in the first 30, applying the power of data-driven genetic insights. You’ll want to hear how Paul and Myriad are empowering patients and physicians to better detect, treat, and prevent disease.
To learn more about the work Paul and Myriad Genetics are doing to lead the way on genetic testing and precision medicine, read Paul’s latest blog post: https://myriad.com/health-illuminated/
